| 注册
首页|期刊导航|疑难病杂志|芪苈强心胶囊对慢性心力衰竭大鼠心脏功能及血浆血管加压素的影响

芪苈强心胶囊对慢性心力衰竭大鼠心脏功能及血浆血管加压素的影响

邬真力 许顶立 林昇 叶桃春 黄鹏 白书昌

疑难病杂志2011,Vol.10Issue(2):120-122,3.
疑难病杂志2011,Vol.10Issue(2):120-122,3.DOI:10.3969/j.issn.1671-6450.2011.02.020

芪苈强心胶囊对慢性心力衰竭大鼠心脏功能及血浆血管加压素的影响

The effects of Qiliqiangxin capsule on cardiac function and the plasma arginine vasopressin of rats with chronic heart failure

邬真力 1许顶立 2林昇 2叶桃春 2黄鹏 2白书昌2

作者信息

  • 1. 010017,呼和浩特,内蒙古自治区医院心内科
  • 2. 510515,广州,南方医科大学南方医院心内科
  • 折叠

摘要

Abstract

Objective To investigate the effects of Qiliqiangxin capsule on the plasma arginine vasopressin ( AVP ) of rats with chronic heart failure ( CHF ). Methods The rats model of CHF was established by ligating the left anterior ascending artery, and then were randomly divided into different doses of Qiliqiangxin capsule treated groups ( Q1, Q2 and Q3 group ), furosemide treatment group ( F group ), CHF group ( C group ) and sham group ( S group ). Cardiac function of rats were detected at the end of 6th week with echocardiogram and hemodynamic parameters. The level of plasma AVP was determined by radioimmunology. Results Comparison with S group, the cardiac function decreased obviously in C group, with the level of plasma AVP was increased( P < 0.01 ). The different dose of Qiliqiangxin capsule treatment groups could improve cardiac function and hemodynamic indexes of animal model. The level of plasma AVP was considerable decreased than that in C group( P <0.05 ). While, there was no significant differences between F group and C group in cardiac function, and the level of plasma AVP in F group was increased dramatically( P < 0.05 ). Conclusion It demonstrated that the Qiliqiangxin capsule could improve cardiac function of CHF rats, which partly contributes to attenuating the plasma AVP.

关键词

血管加压素/心力衰竭,慢性/芪苈强心胶囊/大鼠

引用本文复制引用

邬真力,许顶立,林昇,叶桃春,黄鹏,白书昌..芪苈强心胶囊对慢性心力衰竭大鼠心脏功能及血浆血管加压素的影响[J].疑难病杂志,2011,10(2):120-122,3.

基金项目

国家重点基础研究发展计划(国家973计划)资助项目(No.2005CB523301) (国家973计划)

疑难病杂志

OACSTPCD

1671-6450

访问量0
|
下载量0
段落导航相关论文